Cardiac Safety of Noncardiac Drugs

It is generally easy to define the efficacy of a new the- peutic agent. However, what is even mor...

Cardiac Safety of Noncardiac Drugs

Although it is relatively easy to determine the efficacy of a new drug, it is difficult to establ...

Risk/Benefit Analysis for the Use and Approval of Thrombolytic, Antiarrhythmic, and Hypolipidemic Agents

The Symposium on New Drugs provides a forum for academic investigators, research and development ...

Cardiac Safety of Noncardiac Drugs